Paroxysmal nocturnal hemoglobinuria

New insights from murine pig-a- deficient hematopoiesis

Marcel P DeVetten, J. M. Liu, V. Ling, F. F. Weichold, J. Yu, M. E. Medof, N. S. Young, D. E. Dunn

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

A large fraction of the hematopoietic cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) are deficient in membrane expression of glycosylphosphatidylinositol-anchored proteins (GPI-APs). Current evidence suggests that this deficiency is sufficient to account for the hemolytic and thrombotic manifestations of this disease but not for its frequent association with aplastic anemia, an autoimmune disorder in which the patient's own hematopoietic progenitor cells are the target. Mutations in the X-linked gene PIG-A, encoding one of several enzymes required for the biosynthesis of the glycophosphatidylinositol anchor, have been found in all PNH patients studied to date. Recent experiments with murine Pig-a knock-out embryonic stem cells show that although embryogenesis is critically dependent on normal GPI-AP expression, Pig-a-deficient cells can undergo apparently normal hematopoietic differentiation if they develop in a GPI-AP-replete environment. Thus, in an in vitro mouse model of PNH, Pig-a mutations confer no gross proliferative or differentiative advantage or disadvantage, suggesting an unidentified process selecting for these mutations in the bone marrow of patients with the PNH-aplastic anemia syndrome. The rescue of hematopoiesis observed in chimeric cultures of knock-out and normal cells was accompanied by intercellular transfer of GPI-AP, suggesting exciting new possibilities for future therapeutic manipulations in PNH patients.

Original languageEnglish (US)
Pages (from-to)99-110
Number of pages12
JournalProceedings of the Association of American Physicians
Volume109
Issue number2
StatePublished - Apr 26 1997

Fingerprint

Paroxysmal Hemoglobinuria
Hematopoiesis
Glycosylphosphatidylinositols
Swine
Aplastic Anemia
Mutation
Proteins
X-Linked Genes
Embryonic Stem Cells
Hematopoietic Stem Cells
Embryonic Development
Bone Marrow
Membranes
Enzymes

Keywords

  • aplastic anemia
  • embryonic stem cells
  • glycosylphosphatidyl inositol-anchored proteins
  • hematopoietic stem cells
  • knock-out mice

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DeVetten, M. P., Liu, J. M., Ling, V., Weichold, F. F., Yu, J., Medof, M. E., ... Dunn, D. E. (1997). Paroxysmal nocturnal hemoglobinuria: New insights from murine pig-a- deficient hematopoiesis. Proceedings of the Association of American Physicians, 109(2), 99-110.

Paroxysmal nocturnal hemoglobinuria : New insights from murine pig-a- deficient hematopoiesis. / DeVetten, Marcel P; Liu, J. M.; Ling, V.; Weichold, F. F.; Yu, J.; Medof, M. E.; Young, N. S.; Dunn, D. E.

In: Proceedings of the Association of American Physicians, Vol. 109, No. 2, 26.04.1997, p. 99-110.

Research output: Contribution to journalReview article

DeVetten, MP, Liu, JM, Ling, V, Weichold, FF, Yu, J, Medof, ME, Young, NS & Dunn, DE 1997, 'Paroxysmal nocturnal hemoglobinuria: New insights from murine pig-a- deficient hematopoiesis', Proceedings of the Association of American Physicians, vol. 109, no. 2, pp. 99-110.
DeVetten, Marcel P ; Liu, J. M. ; Ling, V. ; Weichold, F. F. ; Yu, J. ; Medof, M. E. ; Young, N. S. ; Dunn, D. E. / Paroxysmal nocturnal hemoglobinuria : New insights from murine pig-a- deficient hematopoiesis. In: Proceedings of the Association of American Physicians. 1997 ; Vol. 109, No. 2. pp. 99-110.
@article{fab51c5779af476c8ab30342dc943f71,
title = "Paroxysmal nocturnal hemoglobinuria: New insights from murine pig-a- deficient hematopoiesis",
abstract = "A large fraction of the hematopoietic cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) are deficient in membrane expression of glycosylphosphatidylinositol-anchored proteins (GPI-APs). Current evidence suggests that this deficiency is sufficient to account for the hemolytic and thrombotic manifestations of this disease but not for its frequent association with aplastic anemia, an autoimmune disorder in which the patient's own hematopoietic progenitor cells are the target. Mutations in the X-linked gene PIG-A, encoding one of several enzymes required for the biosynthesis of the glycophosphatidylinositol anchor, have been found in all PNH patients studied to date. Recent experiments with murine Pig-a knock-out embryonic stem cells show that although embryogenesis is critically dependent on normal GPI-AP expression, Pig-a-deficient cells can undergo apparently normal hematopoietic differentiation if they develop in a GPI-AP-replete environment. Thus, in an in vitro mouse model of PNH, Pig-a mutations confer no gross proliferative or differentiative advantage or disadvantage, suggesting an unidentified process selecting for these mutations in the bone marrow of patients with the PNH-aplastic anemia syndrome. The rescue of hematopoiesis observed in chimeric cultures of knock-out and normal cells was accompanied by intercellular transfer of GPI-AP, suggesting exciting new possibilities for future therapeutic manipulations in PNH patients.",
keywords = "aplastic anemia, embryonic stem cells, glycosylphosphatidyl inositol-anchored proteins, hematopoietic stem cells, knock-out mice",
author = "DeVetten, {Marcel P} and Liu, {J. M.} and V. Ling and Weichold, {F. F.} and J. Yu and Medof, {M. E.} and Young, {N. S.} and Dunn, {D. E.}",
year = "1997",
month = "4",
day = "26",
language = "English (US)",
volume = "109",
pages = "99--110",
journal = "Proceedings of the Association of American Physicians",
issn = "1081-650X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Paroxysmal nocturnal hemoglobinuria

T2 - New insights from murine pig-a- deficient hematopoiesis

AU - DeVetten, Marcel P

AU - Liu, J. M.

AU - Ling, V.

AU - Weichold, F. F.

AU - Yu, J.

AU - Medof, M. E.

AU - Young, N. S.

AU - Dunn, D. E.

PY - 1997/4/26

Y1 - 1997/4/26

N2 - A large fraction of the hematopoietic cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) are deficient in membrane expression of glycosylphosphatidylinositol-anchored proteins (GPI-APs). Current evidence suggests that this deficiency is sufficient to account for the hemolytic and thrombotic manifestations of this disease but not for its frequent association with aplastic anemia, an autoimmune disorder in which the patient's own hematopoietic progenitor cells are the target. Mutations in the X-linked gene PIG-A, encoding one of several enzymes required for the biosynthesis of the glycophosphatidylinositol anchor, have been found in all PNH patients studied to date. Recent experiments with murine Pig-a knock-out embryonic stem cells show that although embryogenesis is critically dependent on normal GPI-AP expression, Pig-a-deficient cells can undergo apparently normal hematopoietic differentiation if they develop in a GPI-AP-replete environment. Thus, in an in vitro mouse model of PNH, Pig-a mutations confer no gross proliferative or differentiative advantage or disadvantage, suggesting an unidentified process selecting for these mutations in the bone marrow of patients with the PNH-aplastic anemia syndrome. The rescue of hematopoiesis observed in chimeric cultures of knock-out and normal cells was accompanied by intercellular transfer of GPI-AP, suggesting exciting new possibilities for future therapeutic manipulations in PNH patients.

AB - A large fraction of the hematopoietic cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) are deficient in membrane expression of glycosylphosphatidylinositol-anchored proteins (GPI-APs). Current evidence suggests that this deficiency is sufficient to account for the hemolytic and thrombotic manifestations of this disease but not for its frequent association with aplastic anemia, an autoimmune disorder in which the patient's own hematopoietic progenitor cells are the target. Mutations in the X-linked gene PIG-A, encoding one of several enzymes required for the biosynthesis of the glycophosphatidylinositol anchor, have been found in all PNH patients studied to date. Recent experiments with murine Pig-a knock-out embryonic stem cells show that although embryogenesis is critically dependent on normal GPI-AP expression, Pig-a-deficient cells can undergo apparently normal hematopoietic differentiation if they develop in a GPI-AP-replete environment. Thus, in an in vitro mouse model of PNH, Pig-a mutations confer no gross proliferative or differentiative advantage or disadvantage, suggesting an unidentified process selecting for these mutations in the bone marrow of patients with the PNH-aplastic anemia syndrome. The rescue of hematopoiesis observed in chimeric cultures of knock-out and normal cells was accompanied by intercellular transfer of GPI-AP, suggesting exciting new possibilities for future therapeutic manipulations in PNH patients.

KW - aplastic anemia

KW - embryonic stem cells

KW - glycosylphosphatidyl inositol-anchored proteins

KW - hematopoietic stem cells

KW - knock-out mice

UR - http://www.scopus.com/inward/record.url?scp=0030899653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030899653&partnerID=8YFLogxK

M3 - Review article

VL - 109

SP - 99

EP - 110

JO - Proceedings of the Association of American Physicians

JF - Proceedings of the Association of American Physicians

SN - 1081-650X

IS - 2

ER -